A $9 billion biotech deal

A $9 billion biotech deal

Jan 26, 2018 · 30 min

People

Listen on

Suggest an edit

One of the most prominent immunotherapy companies, Juno Therapeutics, announced a deal to be acquired by Celgene. Plus, we dive into the tech renaissance in Pittsburgh and complain about Seattle's bike lanes. Read all our coverage at GeekWire.com. See omnystudio.com/listener for privacy information.

Pittsburgh

Chapters

  1. 0:00 Geek Wire's HQ2 in Pittsburgh
  2. 3:26 Pittsburgh's Tech Renaissance
  3. 5:55 Life Sciences in Pittsburgh
  4. 8:20 Amazon HQ2 Bidding Process
  5. 17:35 Fred Hutch Obliteride
  6. 18:13 Juno Therapeutics Acquired by Celgene
  7. 18:45 Juno's Immunotherapy Research
  8. 20:32 Juno's Clinical Trial Setbacks

Conversation

No comments yet.